By Michelle Fay Cortez
Aug. 25 (Bloomberg) — About half of all cases of penile cancer are linked to a sexually transmitted virus that causes cervical cancer in women and might be prevented with vaccines from Merck & Co. and GlaxoSmithKline Plc, researchers said.
A review of 31 studies involving 1,466 men with penile cancer found the human papillomavirus was present 46.9 percent of the time, according to the report in the Journal of Clinical Pathology. About 26,300 men develop penile cancer each year. It accounts for less than 1 percent of cancers in European and North American men, and up to 10 percent of tumors in men from Africa and Asia, studies show.
Comment from Leslie
Well, this will get the men and boys lined up for the HPV vaccine. I had heard a report earlier this summer about a survery regarding the number of men willing to take Gardasil…and the it was pretty damn low.
Is it any wonder that Merck and GSK concocted this scare tactic to get men to line up to be vaccinated? I mean what motivates a man more than the safety of his penis!